Drugs / 131I-huA33
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00291486 | Oct 2003 → Jan 2008 | colorectal cancer | Ludwig Institute for Cancer Research | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 131I-huA33 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00291486 ↗ |
| Modality | Monoclonal antibody | “humanised A33 monoclonal antibody tagged with radioactive iodine 131” NCT00291486 ↗ |
| Route | Intravenous | “Patients will be given a trace-labelled (small radiation dose) infusion of 131I-huA33 into a vein” NCT00291486 ↗ |